Frazier Life Sciences Public Fund, L.P.

13D and 13G Filings

13D/G filings: 13D on 5 securities, 13G on 27 securities
Location: Palo Alto, CA
CIK: 0001863769
Form D filings: 4 filings
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 5 securities · may seek to influence control
Phathom Pharmaceuticals, Inc. 13D/A PHAT · 71722W107	PHAT	71722W107	7.4%	6,013,327	13D/A	11/2/2026 Event 10/29/2026
Frazier Life Sciences Public Fund, L.P.			6.5%	5,323,356
FHMLSP, L.P.			6.5%	5,323,356
FHMLSP, L.L.C.			6.5%	5,323,356
Frazier Life Sciences X, L.P.			0.1%	59,403
FHMLS X, L.P.			0.1%	59,403
FHMLS X, L.L.C.			0.1%	59,403
Frazier Life Sciences XI, L.P.			1.2%	980,286
FHMLS XI, L.P.			1.2%	980,286
FHMLS XI, L.L.C.			1.2%	980,286
Frazier Life Sciences IX, L.P.			7.2%	5,827,415
FHMLS IX, L.P.			7.2%	5,827,415
FHMLS IX, L.L.C.			7.2%	5,827,416
Frazier Life Sciences XII, L.P.			0.3%	276,029
FHMLS XII, L.P.			0.3%	276,029
FHMLS XII, L.L.C.			0.3%	276,029
James N. Topper			7.4%	6,013,327
Patrick J. Heron			7.3%	5,901,756
Attovia Therapeutics, Inc. 13D ATTO · 04987L102	ATTO	04987L102	13.5%	6,154,213	13D	8/11/2026 Event 8/6/2026
Frazier Life Sciences Public Fund, L.P.			1.7%	760,327
FHMLSP, L.P.			1.7%	760,327
FHMLSP, L.L.C.			1.7%	760,327
Frazier Life Sciences XI, L.P.			13.5%	6,154,213
FHMLS XI, L.P.			13.5%	6,154,213
FHMLS XI, L.L.C.			13.5%	6,154,213
Frazier Life Sciences XII, L.P.			0.1%	54,163
FHMLS XII, L.P.			0.1%	54,163
FHMLS XII, L.L.C.			0.1%	54,163
MBX Biosciences, Inc. 13D/A MBX · 55287L101	MBX	55287L101	11.7%	5,243,421	13D/A	8/10/2026 Event 8/6/2026
Frazier Life Sciences Public Fund, L.P.			3.0%	1,429,573
FHMLSP, L.P.			3.0%	1,429,573
FHMLSP, L.L.C.			3.0%	1,429,573
Frazier Life Sciences X, L.P.			10.8%	5,219,440
FHMLS X, L.P.			10.8%	5,219,440
FHMLS X, L.L.C.			10.8%	5,219,440
Frazier Life Sciences XI, L.P.			0%	3,000
FHMLS XI, L.P.			0%	3,000
FHMLS XI, L.L.C.			0%	3,000
James N. Topper			11.7%	5,219,440
Patrick J. Heron			11.7%	5,243,421
KalVista Pharmaceuticals, Inc. 13D/A KALV · 483497103	KALV	483497103	2.3%	1,249,165	13D/A	5/21/2026 Event 5/19/2026
Frazier Life Sciences Public Fund, L.P.			2.3%	1,249,165
FHMLSP, L.P.			2.3%	1,249,165
FHMLSP, L.L.C.			2.3%	1,249,165
Frazier Life Sciences X, L.P.			0.8%	427,983
FHMLS X, L.P.			0.8%	427,983
FHMLS X, L.L.C.			0.8%	427,983
Frazier Life Sciences XI, L.P.			0.3%	145,592
FHMLS XI, L.P.			0.3%	145,592
FHMLS XI, L.L.C.			0.8%	145,592
Frazier Life Sciences XII, L.P.			0%	6,563
FHMLS XII, L.P.			0%	6,563
FHMLS XII, L.L.C.			0%	6,563
James N. Topper			0.8%	427,983
Patrick J. Heron			0.8%	427,983
HilleVax, Inc. 13D/A HLVX · 43157M102	HLVX	43157M102	0%	0	13D/A	9/17/2025 Event 9/17/2025
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences Public Overage Fund, L.P.			0%	0
FHMLSP Overage, L.P.			0%	0
FHMLSP Overage, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0
Schedule 13G · 27 securities · passive
Q32 Bio Inc. 13G QTTB · 746964105	QTTB	746964105	5.9%	1,755,116	13G	10/9/2026 Event 10/2/2026
Frazier Life Sciences Public Fund, L.P.			5.9%	1,755,116
FHMLSP, L.P.			5.9%	1,755,116
FHMLSP, L.L.C.			5.9%	1,755,116
Frazier Life Sciences XI, L.P.			0.1%	23,029
FHMLS XI, L.P.			0.1%	23,029
FHMLS XI, L.L.C.			0.1%	23,029
Frazier Life Sciences XII, L.P.			0.4%	125,039
FHMLS XII, L.P.			0.4%	125,039
FHMLS XII, L.L.C.			0.4%	125,039
Aclaris Therapeutics, Inc. 13G ACRS · 00461U105	ACRS	00461U105	5.4%	7,879,943	13G	9/21/2026 Event 9/14/2026
Frazier Life Sciences Public Fund, L.P.			5.4%	7,879,943
FHMLSP, L.P.			5.4%	7,879,943
FHMLSP, L.L.C.			5.4%	7,879,943
Frazier Life Sciences XI, L.P.			0.1%	86,910
FHMLS XI, L.P.			0.1%	86,910
FHMLS XI, L.L.C.			0.1%	86,910
Frazier Life Sciences XII, L.P.			0.5%	762,663
FHMLS XII, L.P.			0.5%	762,663
FHMLS XII, L.L.C.			0.5%	762,663
Aura Biosciences, Inc. 13G/A AURA · 05153U107	AURA	05153U107	5.6%	5,807,260	13G/A	8/14/2026 Event 6/30/2026
Frazier Life Sciences Public Fund, L.P.			5.6%	5,807,260
FHMLSP, L.P.			5.6%	5,807,260
FHMLSP, L.L.C.			5.6%	5,807,260
Frazier Life Sciences X, L.P.			0.1%	128,520
FHMLS X, L.P.			0.1%	128,520
FHMLS X, L.L.C.			0.1%	128,520
Frazier Life Sciences XI, L.P.			0.3%	358,810
FHMLS XI, L.P.			0.3%	358,810
FHMLS XI, L.L.C.			0.3%	358,810
Frazier Life Sciences XII, L.P.			0.8%	805,410
FHMLS XII, L.P.			0.8%	805,410
FHMLS XII, L.L.C.			0.8%	805,410
James N. Topper			0.1%	128,520
Patrick J. Heron			0.1%	128,520
Allogene Therapeutics, Inc. 13G/A ALLO · 019770106	ALLO	019770106	5.6%	19,445,046	13G/A	8/14/2026 Event 6/30/2026
Frazier Life Sciences Public Fund, L.P.			5.6%	19,445,046
FHMLSP, L.P.			5.6%	19,445,046
FHMLSP, L.L.C.			5.6%	19,445,046
Frazier Life Sciences X, L.P.			0.1%	306,906
FHMLS X, L.P.			0.1%	306,906
FHMLS X, L.L.C.			0.1%	306,906
Frazier Life Sciences XI, L.P.			0.2%	753,251
FHMLS XI, L.P.			0.2%	753,251
FHMLS XI, L.L.C.			0.2%	753,251
Frazier Life Sciences XII, L.P.			0.6%	1,941,465
FHMLS XII, L.P.			0.6%	1,941,465
FHMLS XII, L.L.C.			0.6%	1,941,465
James N. Topper			0.1%	306,906
Patrick J. Heron			0.1%	306,906
Vor Biopharma Inc. 13G/A VOR · 929033207	VOR	929033207	4.2%	2,258,001	13G/A	8/14/2026 Event 6/30/2026
Frazier Life Sciences Public Fund, L.P.			4.2%	2,258,001
FHMLSP, L.P.			4.2%	2,258,001
FHMLSP, L.L.C.			4.2%	2,258,001
Frazier Life Sciences XI, L.P.			0%	21,114
FHMLS XI, L.P.			0%	21,114
FHMLS XI, L.L.C.			0%	21,114
Frazier Life Sciences XII, L.P.			0.5%	264,824
FHMLS XII, L.P.			0.5%	264,824
FHMLS XII, L.L.C.			0.5%	264,824
Braveheart Bio, Inc. 13G BRVE · 10567X101	BRVE	10567X101	5.5%	4,976,457	13G	8/14/2026 Event 8/7/2026
Frazier Life Sciences Public Fund, L.P.			5.5%	4,976,457
FHMLSP, L.P.			5.5%	4,976,457
FHMLSP, L.L.C.			5.5%	4,976,457
Frazier Life Sciences XI, L.P.			0%	20,361
FHMLS XI, L.P.			0%	20,361
FHMLS XI, L.L.C.			0%	20,361
Frazier Life Sciences XII, L.P.			0.1%	110,554
FHMLS XII, L.P.			0.1%	110,554
FHMLS XII, L.L.C.			0.1%	110,554
Valneva SE 13G VALN · 92025Y103	VALN	92025Y103	3.6%	6,879,516	13G	5/12/2026 Event 5/5/2026
Frazier Life Sciences Public Fund, L.P.			3.6%	6,879,516
FHMLSP, L.P.			3.6%	6,879,516
FHMLSP, L.L.C.			3.6%	6,879,516
Frazier Life Sciences X, L.P.			0.1%	115,500
FHMLS X, L.P.			0.1%	115,500
FHMLS X, L.L.C.			0.1%	115,500
Frazier Life Sciences XI, L.P.			0.2%	337,989
FHMLS XI, L.P.			0.2%	337,989
FHMLS XI, L.L.C.			0.2%	337,989
Frazier Life Sciences XII, L.P.			0.5%	918,572
FHMLS XII, L.P.			0.5%	918,572
FHMLS XII, L.L.C.			0.5%	918,572
James N. Topper			0.1%	115,500
Patrick J. Heron			0.1%	115,500
iBio, Inc. 13G/A IBIO · 451033708	IBIO	451033708	5.7%	1,953,467	13G/A	5/12/2026 Event 3/31/2026
Frazier Life Sciences Public Fund, L.P.			5.7%	1,953,467
FHMLSP, L.P.			5.7%	1,953,467
FHMLSP, L.L.C.			5.7%	1,953,467
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
Frazier Life Sciences XII, L.P.			0%	0
FHMLS XII, L.P.			0%	0
FHMLS XII, L.L.C.			0%	0
Achieve Life Sciences, Inc. 13G ACHV · 004468500	ACHV	004468500	6.5%	6,625,788	13G	4/24/2026 Event 4/17/2026
Frazier Life Sciences Public Fund, L.P.			6.5%	6,625,788
FHMLSP, L.P.			6.5%	6,625,788
FHMLSP, L.L.C.			6.5%	6,625,788
Frazier Life Sciences XI, L.P.			0.1%	61,958
FHMLS XI, L.P.			0.1%	61,958
FHMLS XI, L.L.C.			0.1%	61,958
Frazier Life Sciences XII, L.P.			0.8%	777,090
FHMLS XII, L.P.			0.8%	777,090
FHMLS XII, L.L.C.			0.8%	777,090
Mereo BioPharma Group plc 13G/A MREO · 589492107	MREO	589492107	0%	0	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Lexeo Therapeutics, Inc. 13G/A LXEO · 52886X107	LXEO	52886X107	5.1%	3,698,271	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			5.1%	3,698,271
FHMLSP, L.P.			5.1%	3,698,271
FHMLSP, L.L.C.			5.1%	3,698,271
Frazier Life Sciences X, L.P.			0.1%	87,424
FHMLS X, L.P.			0.1%	87,424
FHMLS X, L.L.C.			0.1%	87,424
Frazier Life Sciences XI, L.P.			0.3%	232,784
FHMLS XI, L.P.			0.3%	232,784
FHMLS XI, L.L.C.			0.3%	232,784
Frazier Life Sciences XII, L.P.			0.6%	406,246
FHMLS XII, L.P.			0.6%	406,246
FHMLS XII, L.L.C.			0.6%	406,246
James N. Topper			0.1%	87,424
Patrick J. Heron			0.1%	87,424
Palvella Therapeutics, Inc. 13G/A PVLA · 697947109	PVLA	697947109	6.0%	706,360	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			6.0%	706,360
FHMLSP, L.P.			6.0%	706,360
FHMLSP, L.L.C.			6.0%	706,360
Frazier Life Sciences X, L.P.			0%	4,730
FHMLS X, L.P.			0%	4,730
FHMLS X, L.L.C.			0%	4,730
Frazier Life Sciences XI, L.P.			0.1%	7,517
FHMLS XI, L.P.			0.1%	7,517
FHMLS XI, L.L.C.			0.1%	7,517
Frazier Life Sciences XII, L.P.			0%	3,793
FHMLS XII, L.P.			0%	3,793
FHMLS XII, L.L.C.			0%	3,793
James N. Topper			0%	4,730
Patrick J. Heron			0%	4,730
Xilio Therapeutics, Inc. 13G/A XLO · 98422T100	XLO	98422T100	6.7%	4,676,472	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			6.7%	4,676,472
FHMLSP, L.P.			6.7%	4,676,472
FHMLSP, L.L.C.			6.7%	4,676,472
Frazier Life Sciences X, L.P.			0.2%	149,060
FHMLS X, L.P.			0.2%	149,060
FHMLS X, L.L.C.			0.2%	149,060
Frazier Life Sciences XI, L.P.			0.6%	396,902
FHMLS XI, L.P.			0.6%	396,902
FHMLS XI, L.L.C.			0.6%	396,902
Frazier Life Sciences XII, L.P.			1.0%	692,657
FHMLS XII, L.P.			1.0%	692,657
FHMLS XII, L.L.C.			1.0%	692,657
James N. Topper			0.2%	149,060
Patrick J. Heron			0.2%	149,060
Maze Therapeutics, Inc. 13G/A MAZE · 578784100	MAZE	578784100	9.0%	4,342,266	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			9.0%	4,342,266
FHMLSP, L.P.			9.0%	4,342,266
FHMLSP, L.L.C.			9.0%	4,342,266
Frazier Life Sciences X, L.P.			0.2%	75,982
FHMLS X, L.P.			0.2%	75,982
FHMLS X, L.L.C.			0.2%	75,982
Frazier Life Sciences XI, L.P.			0.3%	149,026
FHMLS XI, L.P.			0.3%	149,026
FHMLS XI, L.L.C.			0.3%	149,026
Frazier Life Sciences XII, L.P.			0%	0
FHMLS XII, L.P.			0%	0
FHMLS XII, L.L.C.			0%	0
James N. Topper			0.2%	75,982
Patrick J. Heron			0.2%	75,982
Savara Inc. 13G/A SVRA · 805111101	SVRA	805111101	4.1%	8,343,048	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			4.1%	8,343,048
FHMLSP, L.P.			4.1%	8,343,048
FHMLSP, L.L.C.			4.1%	8,343,048
Frazier Life Sciences X, L.P.			0.1%	279,365
FHMLS X, L.P.			0.1%	279,365
FHMLS X, L.L.C.			0.1%	279,365
Frazier Life Sciences XI, L.P.			0.6%	1,239,888
FHMLS XI, L.P.			0.6%	1,239,888
FHMLS XI, L.L.C.			0.6%	1,239,888
James N. Topper			0.1%	279,365
Patrick J. Heron			0.1%	279,365
MacroGenics, Inc. 13G/A MGNX · 556099109	MGNX	556099109	0%	0	13G/A	2/13/2026 Event 12/31/2025
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Adverum Biotechnologies, Inc. 13G/A ADVM · 00773U207	ADVM	00773U207	0%	0	13G/A	12/9/2025 Event 12/9/2025
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
Frazier Life Sciences XII, L.P.			0%	0
FHMLS XII, L.P.			0%	0
FHMLS XII, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Trevi Therapeutics, Inc. 13G/A TRVI · 89532M101	TRVI	89532M101	7.0%	8,508,021	13G/A	11/14/2025 Event 9/30/2025
Frazier Life Sciences Public Fund, L.P.			7.0%	8,508,021
FHMLSP, L.P.			7.0%	8,508,021
FHMLSP, L.L.C.			7.0%	8,508,021
Frazier Life Sciences X, L.P.			0.3%	397,309
FHMLS X, L.P.			0.3%	397,309
FHMLS X, L.L.C.			0.3%	397,309
Frazier Life Sciences XI, L.P.			1.1%	1,354,079
FHMLS XI, L.P.			1.1%	1,354,079
FHMLS XI, L.L.C.			1.1%	1,354,079
James N. Topper			0.3%	397,309
Patrick J. Heron			0.3%	397,309
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0
Jade Biosciences, Inc. 13G/A JBIO · 008064206	JBIO	008064206	4.2%	1,384,646	13G/A	11/14/2025 Event 9/30/2025
Frazier Life Sciences Public Fund, L.P.			4.2%	1,384,646
FHMLSP, L.P.			4.2%	1,384,646
FHMLSP, L.L.C.			4.2%	1,384,646
Frazier Life Sciences X, L.P.			0%	9,488
FHMLS X, L.P.			0%	9,488
FHMLS X, L.L.C.			0%	9,488
Frazier Life Sciences XI, L.P.			0.1%	19,146
FHMLS XI, L.P.			0.1%	19,146
FHMLS XI, L.L.C.			0.1%	19,146
James N. Topper			0%	9,488
Patrick J. Heron			0%	9,488
Disc Medicine, Inc. 13G/A IRON · 254604101	IRON	254604101	3.0%	1,026,489	13G/A	8/14/2025 Event 6/30/2025
Frazier Life Sciences Public Fund, L.P.			3.0%	1,026,489
FHMLSP, L.P.			3.0%	1,026,489
FHMLSP, L.L.C.			3.0%	1,026,489
Frazier Life Sciences Public Overage Fund, L.P.			0.9%	300,643
FHMLSP Overage, L.P.			0.9%	300,643
FHMLSP Overage, L.L.C.			0.9%	300,643
Frazier Life Sciences X, L.P.			0.2%	63,218
FHMLS X, L.P.			0.2%	63,218
FHMLS X, L.L.C.			0.2%	63,218
Frazier Life Sciences XI, L.P.			0.8%	264,484
FHMLS XI, L.P.			0.8%	264,484
FHMLS XI, L.L.C.			0.8%	264,484
James N. Topper			0.2%	63,218
Patrick J. Heron			0.2%	63,218
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0
Erasca, Inc. 13G/A ERAS · 29479A108	ERAS	29479A108	5.3%	15,038,753	13G/A	8/14/2025 Event 6/30/2025
Frazier Life Sciences Public Fund, L.P.			5.3%	15,038,753
FHMLSP, L.P.			5.3%	15,038,753
FHMLSP, L.L.C.			5.3%	15,038,753
Frazier Life Sciences Public Overage Fund, L.P.			0.8%	2,405,634
FHMLSP Overage, L.P.			0.8%	2,405,634
FHMLSP Overage, L.L.C.			0.8%	2,405,634
Frazier Life Sciences X, L.P.			0.6%	1,674,681
FHMLS X, L.P.			0.6%	1,674,681
FHMLS X, L.L.C.			0.6%	1,674,681
Frazier Life Sciences XI, L.P.			1.3%	3,610,368
FHMLS XI, L.P.			1.3%	3,610,368
FHMLS XI, L.L.C.			1.3%	3,610,368
James N. Topper			0.6%	1,674,681
Patrick J. Heron			0.6%	1,674,681
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0
Elevation Oncology, Inc. 13G/A ELEV · 28623U101	ELEV	28623U101	0%	0	13G/A	8/14/2025 Event 7/23/2025
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences Public Overage Fund, L.P.			0%	0
FHMLSP Overage, L.P.			0%	0
FHMLSP Overage, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0
ORIC Pharmaceuticals, Inc. 13G/A ORIC · 68622P109	ORIC	68622P109	2.0%	1,410,193	13G/A	5/15/2025 Event 3/31/2025
Frazier Life Sciences Public Fund, L.P.			0.9%	605,554
FHMLSP, L.P.			0.9%	605,554
FHMLSP, L.L.C.			0.9%	605,554
Frazier Life Sciences Public Overage Fund, L.P.			0.6%	416,494
FHMLSP Overage, L.P.			0.6%	416,494
FHMLSP Overage, L.L.C.			0.6%	416,494
Frazier Life Sciences X, L.P.			0.2%	129,479
FHMLS X, L.P.			0.2%	129,479
FHMLS X, L.L.C.			0.2%	129,479
Frazier Life Sciences XI, L.P.			0.4%	258,666
FHMLS XI, L.P.			0.4%	258,666
FHMLS XI, L.L.C.			0.4%	258,666
James N. Topper			2.0%	1,410,193
Patrick J. Heron			2.0%	1,410,193
Albert Cha			1.4%	1,022,048
James Brush			1.4%	1,022,048
Daniel Estes			0.4%	258,666
AnaptysBio, Inc. 13G/A ANAB · 032724106	ANAB	032724106	1.5%	463,241	13G/A	2/14/2025 Event 1/31/2025
Frazier Life Sciences Public Fund, L.P.			0.5%
FHMLSP, L.P.			0.5%	148,844
FHMLSP, L.L.C.			0.5%	148,844
Frazier Life Sciences Public Overage Fund, L.P.			0.1%	18,902
FHMLSP Overage, L.P.			0.1%	18,902
FHMLSP Overage, L.L.C.			0.1%	18,902
Frazier Life Sciences X, L.P.			0.1%	18,715
FHMLS X, L.P.			0.1%	18,715
FHMLS X, L.L.C.			0.1%	18,715
Frazier Life Sciences XI, L.P.			0.1%	40,222
FHMLS XI, L.P.			0.1%	40,222
FHMLS XI, L.L.C.			0.1%	40,222
Frazier Healthcare VII, L.P.			0.4%	121,206
Frazier Healthcare VII-A, L.P.			0.1%	34,540
FHM VII, L.P.			0.5%	155,746
FHM VII, L.L.C.			0.5%	155,746
James N. Topper			1.5%	463,241
Patrick J. Heron			1.3%	391,539
Albert Cha			0.6%	167,746
James Brush			0.6%	167,746
Daniel Estes			0.1%	40,222
Alan Frazier			0.5%	155,746
Nader Naini			0.5%	155,746
Nathan Every			0.5%	160,369
Brian Morfitt			0.5%	161,115
Eledon Pharmaceuticals, Inc. 13G/A ELDN · 28617K101	ELDN	28617K101	2.0%	1,176,735	13G/A	2/14/2025 Event 12/31/2024
Frazier Life Sciences Public Fund, L.P.			1.5%	878,080
FHMLSP, L.P.			1.5%	878,080
FHMLSP, L.L.C.			1.5%	878,080
Frazier Life Sciences Public Overage Fund, L.P.			0.4%	258,998
FHMLSP Overage, L.P.			0.4%	258,998
FHMLSP Overage, L.L.C.			0.4%	258,998
Frazier Life Sciences X, L.P.			0%	13,062
FHMLS X, L.P.			0%	13,062
FHMLS X, L.L.C.			0%	13,062
Frazier Life Sciences XI, L.P.			0%	26,595
FHMLS XI, L.P.			0%	26,595
FHMLS XI, L.L.C.			0%	26,595
James N. Topper			2.0%	1,176,735
Patrick J. Heron			2.0%	1,176,735
Albert Cha			1.9%	1,137,078
James Brush			1.9%	1,137,078
Daniel Estes			0%	26,595
Puma Biotechnology, Inc. 13G/A PBYI · 74587V107	PBYI	74587V107	0%	0	13G/A	2/14/2025 Event 12/31/2024
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0
AN2 Therapeutics, Inc. 13G/A ANTX · 037326105	ANTX	037326105	0%	0	13G/A	2/14/2025 Event 12/31/2024
Frazier Life Sciences Public Fund, L.P.			0%	0
FHMLSP, L.P.			0%	0
FHMLSP, L.L.C.			0%	0
Frazier Life Sciences X, L.P.			0%	0
FHMLS X, L.P.			0%	0
FHMLS X, L.L.C.			0%	0
Frazier Life Sciences XI, L.P.			0%	0
FHMLS XI, L.P.			0%	0
FHMLS XI, L.L.C.			0%	0
James N. Topper			0%	0
Patrick J. Heron			0%	0
Albert Cha			0%	0
James Brush			0%	0
Daniel Estes			0%	0

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.